GlassScriptPhysician profile
Samuel Meyers
NPI 1659672590
$2,539.94
in general payments reported to CMS, 2019-2025
34 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.63 · 2020: $71.07 · 2021: $125 · 2022: $180 · 2023: $252 · 2024: $1,403 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339 · Long Term Medical Supply Or Device Loan: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.33 |
| Long Term Medical Supply Or Device Loan | $736.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $736.17 | 2024 | Acell |
| Biotissue Holdings INC. | $407.78 | 2022-2024 | |
| Depuy Synthes Sales INC. | $188.10 | 2024-2025 | Na |
| Stryker Corporation | $157.57 | 2019-2022 | |
| Smith+Nephew, INC. | $153.33 | 2019-2024 | Renasys Touch, Stravix, Bone Anchors With Arthroscopic Delivery System |
| Tactile Systems Technology INC | $104.09 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $90.24 | 2024-2025 | Nuzyra |
| Abbvie INC. | $52.71 | 2023 | |
| Curonix LLC | $50.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Treace Medical Concepts, INC. | $47.81 | 2025 | |
| Horizon Therapeutics Plc | $41.89 | 2023 | Krystexxa |
| Medtronic, INC. | $36.66 | 2024 | Intellis Adaptivestim |
| Polynovo North America LLC | $33.87 | 2024 | Novosorb Btm |
| Ani Pharmaceuticals, INC. | $33.16 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $31.85 | 2024 | Bonescalpel & Sonicone (O.R.) |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $27.95 | 2021 | |
| Molnlycke Health Care US, LLC | $27.18 | 2025 | Exufiber, Exufiber Ag+, Mepilex Border Flex |
| Corcept Therapeutics | $26.90 | 2025 | Korlym |
| Davol INC. | $25.95 | 2025 | Arista |
| Amgen INC. | $23.49 | 2024 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.47 | 2023 | Jublia |
| Abbott Laboratories | $23.12 | 2023 | Proclaim |
| Averitas Pharma INC. | $22.15 | 2023 | Qutenza |
| Ermi LLC | $19.69 | 2019 | |
| Surgenex LLC | $19.48 | 2025 | Renograft, Surgraft, Pellograft |
| Azurity Pharmaceuticals, INC. | $18.08 | 2023 | Horizant |
| Advanced Oxygen Therapy INC. | $16.89 | 2025 | Topical Oxygen Chamber For Extremities |
| Paragon 28, INC. | $16.80 | 2020 | |
| Reprise Biomedical, INC. | $16.75 | 2024 | Miro3d |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2023 | Seglentis |
| Lifenet Health | $14.09 | 2023 | |
| Zimmer Biomet Holdings, INC. | $13.78 | 2019 | |
| Wright Medical Technology, INC. | $13.58 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $8.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Meyers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.